are glp-1 covered by medicare Bridge Program: $50 Wegovy, Zepbound, Foundayo (2026) Medicare GLP-1 Bridge Program 2026:
Description
The root cause comes down to one of the key mechanisms that makes GLP-1 medications effective in the first place: delayed gastric emptying
Although long-acting GLP-1 receptor agonists commonly cause nausea, the side effect is typically short-lived, and patients generally tolerate the treatment well
Tolerance patterns change substantially on GLP-1 medications
Serious side effects are possible while using either drug
